Peprostat
Hemorrhage
Haemostatix LtdPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Hemorrhage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tranexamic Acid Daniel Nishijima, MD, MAS | Phase 4 | BBB |
CHLORHEXIDINE Beijing Tiantan Hospital | Phase 4 | BB |
Plavix Chonnam National University Hospital | Phase 4 | BB |
PROPRANOLOL Shanghai Zhongshan Hospital | Phase 4 | BB |
Acetylsalicylic Acid Chonnam National University Hospital | Phase 4 | BB |
View all 20 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →